These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2903265)

  • 1. [Expression of LeX antigens in renal adenocarcinoma differentiation and the prognosis].
    Fukushi Y; Saito S; Orikasa S; Ohtani H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1090-5. PubMed ID: 2903265
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of lacto series type 2 antigens in human renal cell carcinoma and its clinical significance.
    Fukushi Y; Ohtani H; Orikasa S
    J Natl Cancer Inst; 1989 Mar; 81(5):352-8. PubMed ID: 2563403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of SSEA-1 on human renal tumors.
    Liebert M; Jaffe R; Taylor RJ; Ballou BT; Solter D; Hakala TR
    Cancer; 1987 Apr; 59(8):1404-8. PubMed ID: 2880658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical characterization of renal cell carcinomas].
    Bohle B; Waldherr R; Schwechheimer K; Moldenhauer G; Momburg F
    Verh Dtsch Ges Pathol; 1986; 70():274-8. PubMed ID: 3825252
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA class I expression in primary and metastatic renal cell carcinoma.
    Buszello H; Ackermann R
    Investig Urol (Berl); 1994; 5():55-9. PubMed ID: 7719321
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigen expression in renal cell carcinoma. Correlation with histological grade, pathological stage and development of distant metastasis.
    Reuter VE
    Eur Urol; 1990; 18 Suppl 2():4-5. PubMed ID: 2226607
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating cancer cells in renal-cell carcinoma.
    Pontes JE; Pescatori E; Connelly R; Hashimura T; Tubbs R
    Prog Clin Biol Res; 1990; 348():1-12. PubMed ID: 2385602
    [No Abstract]   [Full Text] [Related]  

  • 8. The operable renal cell carcinoma: summary and conclusions.
    deKernion JB; Huland H
    Eur Urol; 1990; 18 Suppl 2():48-51. PubMed ID: 2226611
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular origin of renal cell carcinoma--an immunohistological study on monoclonal antibodies.
    Gu FL; Cai SL; Cai BJ; Wu CP
    Scand J Urol Nephrol Suppl; 1991; 138():203-6. PubMed ID: 1785005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen diffusion and uptake: a caveat in immunohistochemical interpretation.
    Alpern HD
    Mod Pathol; 1992 Sep; 5(5):575-6. PubMed ID: 1344823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of Lex and dimeric Lex haptens and their sialylated antigens during development of human kidney and kidney tumors.
    Fukushi Y; Orikasa S; Shepard T; Hakomori S
    J Urol; 1986 May; 135(5):1048-56. PubMed ID: 3007781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of proliferation rates to prognosis in human renal cell carcinoma.
    de Riese W; Allhoff EP; Liedke S; Lenis G; Stief CG; Werner M; Atzpodien J; Kirchner H
    Eur J Cancer; 1993; 29A(7):1072-3. PubMed ID: 8499141
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression of 3-fucosylated-N-acetyl lactosamine carbohydrate determinants in renal tumours.
    Fleming S; Brown G
    Histopathology; 1987 Feb; 11(2):171-82. PubMed ID: 3032763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine embryonal carcinoma cell-surface sialyl LeX is present on a novel glycoprotein and on high-molecular-weight lactosaminoglycan.
    Rosenman SJ; Fenderson BA; Hakomori SI
    Exp Cell Res; 1989 Feb; 180(2):326-40. PubMed ID: 2464500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures.
    Trojaneck B; Niemitz S; Micka B; Lefterova P; Blasczyk R; Scheffold C; Huhn D; Schmidt-Wolf IG
    Cancer Biother Radiopharm; 2000 Apr; 15(2):169-74. PubMed ID: 10803322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical study of renal cell carcinoma with monoclonal anti Leu-M1 antibody].
    Senga Y; Satomi Y; Fukuda M; Ebato T; Hosaka M; Tanaka Y; Misugi K
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1246-51. PubMed ID: 3500350
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
    Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
    Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological investigation of SSEA-1 antigen and its derivatives in the serum in urological malignancies].
    Fukushi Y; Orikasa S; Kannagi R; Hakomori S
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):232-7. PubMed ID: 2886692
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies to renal cancer antigens.
    Bander NH
    Eur Urol; 1990; 18 Suppl 2():10-2. PubMed ID: 2226594
    [No Abstract]   [Full Text] [Related]  

  • 20. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.